Cause of death, by non-communicable diseases, ages 15-59, female in Belize
Belize: Cause of death, by non-communicable diseases, ages 15-59, female was 61.7% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 15-59, female in Belize, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 15-59.
Analysis
Belize recorded 61.7% for cause of death, by non-communicable diseases, ages 15-59, female in 2021.
That represents a change of down 4.6% on the previous year and down 5.4% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, female in Belize peaked at 65.2% in 2010 and was at its lowest, 60.3%, in 2000.
That places Belize 92nd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59, female in Belize, year by year
| Year | % of total female deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 60.3% | — |
| 2010 | 65.2% | +8.2% |
| 2015 | 64.1% | -1.7% |
| 2019 | 64.5% | +0.6% |
| 2020 | 64.7% | +0.3% |
| 2021 | 61.7% | -4.6% |
Belize compared with similar countries
- Belize's 61.7% is above the median for upper middle income countries, which is 60.9%, 1.0× the median. (55 countries reporting)
- Belize's 61.7% is above the median for Latin America & Caribbean, which is 60.1%, 1.0× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.3% | 60.3% | 60.3% | 1 |
| 2010s | 64.6% | 64.1% | 65.2% | 3 |
| 2020s | 63.2% | 61.7% | 64.7% | 2 |
Countries ranked near Belize
More health data for Belize
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5114 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,415 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.566 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0412 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.6604 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, female in Belize?
- Cause of death, by non-communicable diseases, ages 15-59, female in Belize was 61.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, female recorded in Belize?
- The highest recorded value was 65.2% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, female recorded in Belize?
- The lowest recorded value was 60.3% in 2000.
- How does Belize rank for cause of death, by non-communicable diseases, ages 15-59, female?
- Belize ranks 92nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, female rising or falling in Belize?
- Over the last ten years it is down 5.4%. The long-run trend across the full record is flat.
- Where does this Belize data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.